A First-in-Human Study of LY3009385 in Healthy Participants

Clinical trial NCT01477567 · COMPLETED

Trial details

NCT number: NCT01477567
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Diabetes Mellitus, Type 2

Start date: 2011-11-01
Primary completion: 2012-03-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.